533 results on '"Weinberg, Benjamin"'
Search Results
2. Cancer survivor preferences on the timing and content of interventions to mitigate financial toxicity associated with cancer treatment
3. Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail
4. Social and environmental variables as predictors of mania: a review of longitudinal research findings
5. Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
6. Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
7. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
8. Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
9. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
10. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
11. Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.
12. Uncovering actionable genetic alterations and immune predictive biomarkers for anal squamous cell carcinomas in the era of immunotherapy: PD-L1 and beyond.
13. Characterization of necroptosis activators in colorectal cancer.
14. Predator odor (TMT) exposure potentiates interoceptive sensitivity to alcohol and increases GABAergic gene expression in the anterior insular cortex and nucleus accumbens in male rats
15. The current state of molecular profiling in gastrointestinal malignancies
16. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
17. Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options
18. Conceptualizing Chance: The hodos in Homer
19. Metastatic Colorectal Cancer
20. Identification and characterization of immunogenic neoantigens in colorectal cancer (CRC).
21. Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).
22. Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.
23. Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.
24. Impact of next-generation sequencing in biliary tract cancer treatment.
25. Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.
26. Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).
27. Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease.
28. Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
29. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
30. Genomics and transcriptomics of pancreatic adenosquamous carcinoma.
31. Changes in circulating immune biomarkers following nivolumab with or without ipilimumab for metastatic anal cancer (NCI9673).
32. Scalable recombinase-based gene expression cascades
33. Quantitative characterization of recombinase-based digitizer circuits enables predictable amplification of biological signals
34. Vaccine Therapy in Pancreatic Cancer
35. 716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or gastroesophageal cancer
36. Phase I Study of Hypofractionated Proton Beam Radiotherapy in Adjuvant Pancreatic Cancer (PROTON-PANC)
37. Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options
38. Therapeutic Cancer Vaccines
39. Molecular Profiling in Metastatic Colorectal Cancer
40. Parmenides’ hodos dizēsios, Models, and the Emergence of
41. A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.
42. Phase 1 Study of Hypofractionated Proton Beam Radiation Therapy in Adjuvant Pancreatic Cancer (PROTON-PANC).
43. Microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) across gastrointestinal (GI) malignancies.
44. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
45. Data from The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
46. Supplementary Table S2 from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
47. Supplemental File 1 from The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
48. Data from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
49. Supplemental Table 1 from The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
50. Supplemental Table 2 from The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.